Viewpoint: CRISPR crop regulations should be based on the final product, not on the nearly undetectable process of producing new plants

mm
Credit: Michael Major/Global Crop Diversity Trust (CC BY-NC-SA 2.0)

The adoption of new technologies by plant breeders and developers depends on clear, predictable, risk-proportionate regulation and the breadth of its application to potential products. Many countries have recently put forth regulations that exempt or exclude plants produced through gene editing from regulations that authorize the use of transgenic plants for cultivation, food, feed or processing. However, differences in key elements of these exemptions or exclusions means overall utility for plant breeding innovation varies greatly.

Follow the latest news and policy debates on sustainable agriculture, biomedicine, and other ‘disruptive’ innovations. Subscribe to our newsletter.

This severely limits the ability of developers of new plant varieties produced using gene editing tools from conducting large scale, open-field evaluations, as is customary in conventional breeding programs.

In short, regulation based on process will not advance common goals of nutrition, sustainability or consumer preference. On the contrary, process-based regulation will only delay or prevent the achievement of these goals. Differential requirements lead to a confusing system with higher burdens, lower utility and increased time to market. This only creates disincentive to fund research and business investment, and ultimately throws up barriers to reaching consumers and improving diets for even the simplest and most-familiar of characteristics. When science cannot distinguish one seedless grape from another, neither should regulation.

This is an excerpt. Read the original post here

{{ reviewsTotal }}{{ options.labels.singularReviewCountLabel }}
{{ reviewsTotal }}{{ options.labels.pluralReviewCountLabel }}
{{ options.labels.newReviewButton }}
{{ userData.canReview.message }}
skin microbiome x final

Infographic: Could gut bacteria help us diagnose and treat diseases? This is on the horizon thanks to CRISPR gene editing

Humans are never alone. Even in a room devoid of other people, they are always in the company of billions ...
glp menu logo outlined

Newsletter Subscription

* indicates required
Email Lists
glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.